"Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program MedeA in the Extremadura Health Service."
RecruitingOBSERVATIONAL
Enrollment
6,445
Participants
Timeline
Start Date
May 26, 2021
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Conditions
Adverse Drug Event
Trial Locations (1)
06080
RECRUITING
Complejo Hospitalario Universitario de Badajoz, Badajoz
All Listed Sponsors
lead
Complejo Hospitalario Universitario de Badajoz
OTHER
NCT06607445 - "Evaluation of the Implementation of the Pharmacogenetics and Personalized Medicine Program MedeA in the Extremadura Health Service." | Biotech Hunter | Biotech Hunter